| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |